Wnt/β-Catenin signaling is a well-known pathway used by cancer cells for multiple malignancy-associated functions including SLC properties [39], as demonstrated in COX-2 over-expressing breast cancer cells [6]. This evidence concerns the gene PTGS2 and breast carcinoma.